-
Mashup Score: 4
Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Interdisciplinary approaches help reduce asthma burden - 3 year(s) ago
Clinicians are encouraged to team with school employees, asthma educators and patient advocates to improve the health and well-being of patients with asthma, panelists said.The speakers described three different interdisciplinary programs they spearhead during a symposium session of the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 3
Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
A panel of experts at the virtual American Academy of Allergy, Asthma and Immunology Annual Meeting highlighted current evidence on allergic reactions to available COVID-19 vaccines and how to assess patients who have had a reaction.“In the clinical trials with [the messenger RNA] vaccines involving tens of thousands of patients, there were no anaphylactic reactions reported, but on the
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 3Benralizumab eliminates oral corticosteroid use in certain patients with severe asthma - 3 year(s) ago
Patients with oral corticosteroid-dependent asthma treated with benralizumab achieved OCS elimination or reduction in those in whom adrenal insufficiency was detected, regardless of baseline eosinophil count, in the PONENTE trial.The multicenter, open-label, single-arm phase 3b trial evaluated the safety and efficacy of daily OCS dose reduction following initiation of benralizumab (Fasenra,
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Minority Participation in Food Allergy Trials Remains Low - 3 year(s) ago
Increasing participation is a significant unmet challenge, researcher says
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Cause of chronic cough unknown in 37% of primary care patients - 3 year(s) ago
The cause of chronic cough remained unexplained in more than one-third of patients 3.5 years after they first presented to a primary care physician for the condition, researchers wrote. The findings were published in an online supplement to The Journal of Allergy and Clinical Immunology on Feb. 1 and presented during the American Academy of Allergy, Asthma and Immunology recent annual meeting,
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 22Masks Don't Affect Oxygen Saturation in People With Asthma - 3 year(s) ago
People with asthma sometimes worry that wearing a mask against COVID-19 won’t let them breathe. But a new study demonstrates masks don’t affect oxygen saturation.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
Dupilumab treatment led to clinical #asthma remission in patients with uncontrolled moderate to severe asthma, according to study presented at #AAAAI21 https://t.co/Ud7CLzjFPI